A0A091ER56 (A0A091ER56_FUKDA) Fukomys damarensis (Damaraland mole rat) (Cryptomys damarensis)

Stress-activated protein kinase JNK UniProtKBInterProSTRINGInteractive Modelling

464 aa; Sequence (Fasta) ; 9 identical sequences: Homo sapiens: P53779; Pan troglodytes: A0A2J8L2H3; Macaca mulatta: A0A1D5QMC7, A0A8J8YAK3; Macaca fascicularis: A0A2K5TUM6; Sapajus apella: A0A6J3ENL5; Saimiri boliviensis boliviensis: A0A2K6U2B1; Carlito syrichta: A0A1U7T522; Orycteropus afer afer: A0A8B7AHP2

Available Structures

61 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of JNK3 in Complex with JIP1 Peptide
4h39
 Heteromer
P53779; Q9UQF2; 		45-400
Assess
Crystal Structure of JNK3 in Complex with SAB Peptide
4h3b
 Heteromer
O60239; P53779; 		45-400
Assess
Design and Synthesis of a Novel, Orally Efficacious Tri-substituted Thiophene Based JNK Inhibitor
3ptg
 Heteromer
P53779; Q9UQF2; 		46-401
1×932;
Assess
Crystal Structure of JNK3 in Complex with ATF2 Peptide
4h36
 Heteromer
P15336; P53779; 		45-400
Assess
Design and Synthesis of Disubstituted Thiophene and Thiazole Based Inhibitors of JNK for the Treatm…
3oxi
 Heteromer
P53779; Q9UQF2; 		46-400
1×SYY;
Assess
Crystal structure of JNK3 in complex with light-activated covalent inhibitor MR-II-249 with both no…
7ore
monomer44-402
2×0EI; 9×EDO;
Assess
Crystal structure of JNK3 in complex with FMU-001-367 (compound 1)
7orf
monomer45-401
1×0G3; 20×EDO; 1×MES;
Assess
The Crystal Structure of JNK3 from Biortus.
8wgf
monomer44-400
1×ANP; 1×MG;
Assess
Crystal structure of JNK3 with indazole inhibitor, SR-3737
3fi3
monomer45-401
1×JK2; 2×EDO;
Assess
Crystal structure of human JNK3 in complex with a benzenesulfonamide inhibitor.
4u79
monomer44-400
1×3EL;
Assess
Discovery of potent and selective covalent inhibitors of JNK
3v6r
monomer45-401
1×CQQ;
Assess
Discovery of potent and selective covalent inhibitors of JNK
3v6s
monomer45-401
1×0F0;
Assess
Thiophenyl-Pyrazolourea Derivatives as Potent, Brian Penetrant, Orally Bioavailable, and Isoform-Se…
7ksi
monomer45-400
1×X3S;
Assess
Design and Synthesis of Highly Potent and Isoform Selective JNK3 Inhibitors: SAR Studies on Aminopy…
4whz
monomer45-400
1×3NL;
Assess
Thiophenyl-Pyrazolourea Derivatives as Potent, Brian Penetrant, Orally Bioavailable, and Isoform-Se…
7ksk
monomer45-400
1×X3V;
Assess
JNK2/3 in complex with N-(2-methylpyridin-4-yl)-3-{4-[(phenylcarbamoyl)amino]-1H-pyrazol-1-yl}benza…
4w4w
monomer45-400
1×3HJ;
Assess
The crystal structure of inhibitor-bound JNK3
4kkh
monomer45-400
1×1RQ;
Assess
Crystal Structure of human JNK3 complexed with N-(3-methyl-4-(3-(2-(methylamino)pyrimidin-4-yl)pyri…
3da6
monomer46-401
1×BZ9;
Assess
Crystal Structure of human JNK3 complexed with an isoquinolone inhibitor
2zdt
monomer45-400
1×46C; 1×GOL;
Assess
JNK2/3 in complex with 3-(4-{[(2-chlorophenyl)carbamoyl]amino}-1H-pyrazol-1-yl)-N-(2-methylpyridin-…
4w4v
monomer45-400
1×3H8;
Assess
Pyridopyrimidinone Derivatives as Potent and Selective c-Jun N-Terminal Kinase (JNK) inhibitors
4y46
monomer45-400
1×4F2;
Assess
Pyridopyrimidinone Derivatives as Potent and Selective c-Jun N-Terminal Kinase (JNK) inhibitors
4y5h
monomer45-400
1×519;
Assess
Thiophenyl-Pyrazolourea Derivatives as Potent, Brian Penetrant, Orally Bioavailable, and Isoform-Se…
7ksj
monomer45-400
1×X3Y;
Assess
THE STRUCTURE OF JNK3 IN COMPLEX WITH AN IMIDAZOLE-PYRIMIDINE INHIBITOR
4z9l
monomer45-400
1×ANP; 1×880; 3×UNX;
Assess
N-Aromatic-Substituted Indazole Derivatives as Brain Penetrant and Orally Bioavailable JNK3 Inhibit…
7s1n
monomer45-400
1×86C;
Assess
Crystal structure of JNK3 in complex with an imidazole-pyrimidine inhibitor
1pmn
monomer45-400
1×984;
Assess
The crystal structure of AMP-bound JNK3
4kke
monomer45-400
1×AMP;
Assess
Crystal structure of JNK3 with amino-pyrazole inhibitor, SR-3451
3fi2
monomer45-400
1×JK1; 1×EDO;
Assess
JNK2/3 in complex with 3-(4-{[(4-methylphenyl)carbamoyl]amino}-1H-pyrazol-1-yl)-N-(2-methylpyridin-…
4w4y
monomer45-400
1×3HQ;
Assess
THE C-JUN N-TERMINAL KINASE (JNK3S) COMPLEXED WITH MGAMP-PNP
1jnk
monomer45-400
2×MG; 1×ANP;
Assess
JNK3 bound to aminopyrimidine inhibitor, SR-3562
3kvx
monomer46-401
1×FMY;
Assess
Synthesis and SAR of Aminopyrimidines as Novel c-Jun N-Terminal Kinase (JNK) Inhibitors
2p33
monomer45-400
1×J07;
Assess
c-Jun N-terminal Kinase 3 with 3,5-Disubstituted Quinoline inhibitor
2r9s
monomer46-401
1×255; 17×UNX; 1×TFA; 4×EDO;
Assess
Crystal structure of apo and AMP-bound JNK3
4kkg
monomer45-400
Assess
Crystal structure of JNK3 in complex with a fragment molecule
7yl1
monomer45-400
1×J6F;
Assess
The structure of JNK3 in complex with a dihydroanthrapyrazole inhibitor
1pmv
monomer45-400
1×537;
Assess
JNK2/3 in complex with 3-(4-{[(4-fluorophenyl)carbamoyl]amino}-1H-pyrazol-1-yl)-N-(2-methylpyridin-…
4w4x
monomer45-400
1×3HN;
Assess
The crystal structure of JNK3 in complex with a phenantroline inhibitor
1pmu
monomer45-400
1×CL; 1×9HP;
Assess
Inhibitor complex of JNK3
2exc
monomer45-400
1×JNK;
Assess
JNK3 bound to (Z)-1-((6-fluoro-4H-benzo[d][1,3]dioxin-8-yl)methyl)-3-(hydroxyimino)-4-phenylindolin…
3g9n
monomer45-400
1×J88;
Assess
Design, synthesis, biological evaluation, and X-ray crystallography of diarylpyrazole derivatives p…
8enj
monomer45-400
1×WNK;
Assess
IRAK-4 Inhibitors (Part II)- A structure based assessment of imidazo[1,2 a]pyridine binding
3cgo
monomer45-400
1×JNO;
Assess
IRAK-4 Inhibitors (Part II)- A structure based assessment of imidazo[1,2 a]pyridine binding
3cgf
monomer45-400
1×JNF;
Assess
Highly Selective c-Jun N-Terminal Kinase (JNK) 2 and 3 Inhibitors with In Vitro CNS-like Pharmacoki…
3oy1
monomer46-400
1×589;
Assess
Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor
6emh
monomer46-400
2×BME; 1×CL; 1×BGE; 1×EDO; 1×C15;
Assess
Crystal structure of JNK3 in complex with AMP-PCP
6eq9
monomer46-400
1×MG; 2×NA; 1×BME; 1×ACP; 1×C15; 1×PEG;
Assess
JNK3 (Mitogen-activated protein kinase 10) in Complex with Compound 23 bearing a C(sp3)F2Br moiety
8bzp
monomer46-400
1×SWM; 4×EDO; 3×GOL; 1×BME; 2×PEG; 1×C15;
Assess
inhibitor complex of JNK3
2b1p
monomer46-400
1×SO4; 1×AIZ; 1×BME;
Assess
The MAP kinase JNK3 as target for halogen bonding
4x21
monomer46-400
1×3WH; 1×CL;
Assess
Crystal structure of human JNK3 complexed with N-{3-cyano-6-[3-(1-piperidinyl)propanoyl]-4,5,6,7-te…
2o0u
monomer46-400
1×C0M;
Assess
Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor
6ekd
monomer46-400
1×BME; 1×EDO; 1×B9K;
Assess
Crystal Structure of JNK3 complexed with CC-359, a JNK inhibitor for the prevention of ischemia-rep…
3ttj
monomer46-400
1×JBI;
Assess
JNK3 bound to (Z)-1-((6-fluoro-4H-benzo[d][1,3]dioxin-8-yl)methyl)-3-(hydroxyimino)-4-styrylindolin…
3g9l
monomer46-400
1×J67;
Assess
Crystal Structure of JNK3 complexed with CC-930, an orally active anti-fibrotic JNK inhibitor
3tti
monomer46-400
1×KBI; 1×GOL;
Assess
JNK3 bound to piperazine amide inhibitor, SR2774.
3fv8
monomer46-400
1×JK3; 5×EDO;
Assess
Crystal structure of human Jnk3 complexed with a 1-aryl-3,4- dihydroisoquinoline inhibitor
2waj
monomer46-400
1×SNB;
Assess
Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic prop…
3rtp
monomer46-400
1×34I;
Assess
JNK-3 bound to (Z)-5-fluoro-1-((6-fluoro-4H-benzo[d][1,3]dioxin-8-yl)methyl)-3-(hydroxyimino)indoli…
3g90
monomer46-400
1×J72;
Assess
Crystal structure of JNK3 bound to N-benzyl-4-(4-(3-chlorophenyl)-1H-pyrazol-3-yl)-1H-pyrrole-2-car…
2ok1
monomer46-400
1×33A;
Assess
Crystal structure of human JNK3 complexed with N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-f…
2o2u
monomer46-400
1×738;
Assess
Crystal Structure of human JNK3 complexed with an isoquinolone inhibitor
2zdu
monomer46-400
1×446;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7yl1.1.Amonomer0.8345-400
1×J6F;100.00
Assess